Structural basis of Smad2 recognition by the Smad anchor for receptor activation
- PMID: 10615055
- DOI: 10.1126/science.287.5450.92
Structural basis of Smad2 recognition by the Smad anchor for receptor activation
Abstract
The Smad proteins mediate transforming growth factor-beta (TGFbeta) signaling from the transmembrane serine-threonine receptor kinases to the nucleus. The Smad anchor for receptor activation (SARA) recruits Smad2 to the TGFbeta receptors for phosphorylation. The crystal structure of a Smad2 MH2 domain in complex with the Smad-binding domain (SBD) of SARA has been determined at 2.2 angstrom resolution. SARA SBD, in an extended conformation comprising a rigid coil, an alpha helix, and a beta strand, interacts with the beta sheet and the three-helix bundle of Smad2. Recognition between the SARA rigid coil and the Smad2 beta sheet is essential for specificity, whereas interactions between the SARA beta strand and the Smad2 three-helix bundle contribute significantly to binding affinity. Comparison of the structures between Smad2 and a comediator Smad suggests a model for how receptor-regulated Smads are recognized by the type I receptors.
Similar articles
-
SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.Cell. 1998 Dec 11;95(6):779-91. doi: 10.1016/s0092-8674(00)81701-8. Cell. 1998. PMID: 9865696
-
The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.Mol Cell. 2001 Sep;8(3):671-82. doi: 10.1016/s1097-2765(01)00332-x. Mol Cell. 2001. PMID: 11583628
-
Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.Biochem Biophys Res Commun. 2001 Mar;281(5):1100-5. doi: 10.1006/bbrc.2001.4489. Biochem Biophys Res Commun. 2001. PMID: 11243848
-
The Smad pathway.Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):5-13. doi: 10.1016/s1359-6101(99)00024-6. Cytokine Growth Factor Rev. 2000. PMID: 10708948 Review.
-
From receptor to nucleus: the Smad pathway.Curr Opin Genet Dev. 1997 Aug;7(4):467-73. doi: 10.1016/s0959-437x(97)80072-x. Curr Opin Genet Dev. 1997. PMID: 9309176 Review.
Cited by
-
Targeted dephosphorylation of SMAD3 as an approach to impede TGF-β signaling.iScience. 2024 Jul 5;27(8):110423. doi: 10.1016/j.isci.2024.110423. eCollection 2024 Aug 16. iScience. 2024. PMID: 39104417 Free PMC article.
-
Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.Pharmaceuticals (Basel). 2024 Mar 1;17(3):326. doi: 10.3390/ph17030326. Pharmaceuticals (Basel). 2024. PMID: 38543112 Free PMC article. Review.
-
Genetic retargeting of E3 ligases to enhance CAR T cell therapy.Cell Chem Biol. 2024 Feb 15;31(2):338-348.e5. doi: 10.1016/j.chembiol.2023.10.024. Epub 2023 Nov 20. Cell Chem Biol. 2024. PMID: 37989314
-
Computational and Experimental Analyses for Pathogenicity Prediction of ACVRL1 Missense Variants in Hereditary Hemorrhagic Telangiectasia.J Clin Med. 2023 Jul 29;12(15):5002. doi: 10.3390/jcm12155002. J Clin Med. 2023. PMID: 37568404 Free PMC article.
-
Intricacies of TGF-β signaling in Treg and Th17 cell biology.Cell Mol Immunol. 2023 Sep;20(9):1002-1022. doi: 10.1038/s41423-023-01036-7. Epub 2023 May 23. Cell Mol Immunol. 2023. PMID: 37217798 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases